SUPPORTING THE DEVELOPMENT OF POTENTIAL CURES

Live / Registered — Registered (as of 02 May 2023)

What this means for you

Registered since 02 May 2023. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97169506
Registration number
7040283
Mark type
Stylized text
Filed
13 Dec 2021
Published for opposition
14 Feb 2023
Registered
02 May 2023
Attorney of record
JOHN P. MURTAUGH

Goods and services

  • Class 035 — Advertising and business services: Assistance, advisory services and consultancy with regard to business planning; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting services; Business consulting services in the field of potential medical cures including cell and gene therapies; Business consultation in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, chemistry, manufacturing and controls, and quality assurance/quality control; Business consulting services, namely, providing assistance in development of business strategies and creative ideation; Business management consulting and advisory services; Business support services, namely, business consulting to freelancers, start-ups, existing businesses and non-profit organizations; Consultancy and advisory services in the field of business strategy; Consulting services in the field of medical product approval for commercial purposes; International business consulting services relating to USA and outside of USA product, clinical and commercial development of investigational or approved medical products; New business venture development and formation consulting services; Promoting the exchange of information and resources within the scientific research communities to achieve advances in the field of 21st century transformational science; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Providing independent review of clinical trials for business purposes; Promoting technical and scientific investigation, research and experimentation in the field of scientific discovery through support of educational institutions and scientific organizations
  • Class 036 — Insurance and financial services: Financial consulting services, namely, advising others regarding intellectual property investments; Investment consultation in the fields of product, technical, regulatory, preclinical, clinical, and commercial diligence for innovative potential or investigational medical products
  • Class 042 — Scientific and technological services: Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research information in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, manufacturing/CMC and quality assurance/quality control; Providing information about medical and scientific research; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific and technological services, namely, scientific research in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Scientific research consulting in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Scientific research and development; Technological planning and consulting services in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific consulting and research services relating to foods and dietary supplements; Scientific research consulting in the field of cosmetics
  • Class 044 — Medical, beauty and agricultural services: Consulting services in the field of health; Consulting services to health care providers in the field of treating life-changing or life-threatening diseases

Owner

Prosecution history

  • 02 May 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 02 May 2023 — REGISTERED-PRINCIPAL REGISTER
  • 14 Feb 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 14 Feb 2023 — PUBLISHED FOR OPPOSITION
  • 25 Jan 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 09 Jan 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 28 Dec 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 27 Dec 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 27 Dec 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 17 Nov 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 17 Nov 2022 — NON-FINAL ACTION E-MAILED
  • 17 Nov 2022 — NON-FINAL ACTION WRITTEN
  • 11 Nov 2022 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
  • 04 Oct 2022 — WITHDRAWN FROM PUB - OG REVIEW QUERY
  • 20 Sept 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER

View this trademark record on Marksy